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Abstract
Background: Adequate normalization minimizes the effects of systematic technical variations and is a prerequisite for
getting meaningful biological changes. However, there is inconsistency about miRNA normalization performances and
recommendations. Thus, we investigated the impact of seven different normalization methods (reference gene index, global
geometric mean, quantile, invariant selection, loess, loessM, and generalized procrustes analysis) on intra- and inter-
platform performance of two distinct and commonly used miRNA profiling platforms.
Methodology/Principal Findings: We included data from miRNA profiling analyses derived from a hybridization-based
platform (Agilent Technologies) and an RT-qPCR platform (Applied Biosystems). Furthermore, we validated a subset of
miRNAs by individual RT-qPCR assays. Our analyses incorporated data from the effect of differentiation and tumor
necrosis factor alpha treatment on primary human skeletal muscle cells and a murine skeletal muscle cell line. Distinct
normalization methods differed in their impact on (i) standard deviations, (ii) the area under the receiver operating
characteristic (ROC) curve, (iii) the similarity of differential expression. Loess, loessM, and quantile analysis were most
effective in minimizing standard deviations on the Agilent and TLDA platform. Moreover, loess, loessM, invariant
selection and generalized procrustes analysis increased the area under the ROC curve, a measure for the statistical
performance of a test. The Jaccard index revealed that inter-platform concordance of differential expression tended to
be increased by loess, loessM, quantile, and GPA normalization of AGL and TLDA data as well as RGI normalization of
TLDA data.
Conclusions/Significance: We recommend the application of loess, or loessM, and GPA normalization for miRNA Agilent
arrays and qPCR cards as these normalization approaches showed to (i) effectively reduce standard deviations, (ii) increase
sensitivity and accuracy of differential miRNA expression detection as well as (iii) increase inter-platform concordance.
Results showed the successful adoption of loessM and generalized procrustes analysis to one-color miRNA profiling
experiments.
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Introduction
MicroRNA (miRNA) expression profiling has become a
standard bioanalytical technique and provides a first important
step in characterizing the role of miRNAs, a class of small (21–
24 nucleotides) noncoding RNAs which regulates gene expres-
sion at the posttranscriptional level (reviewed in [1]). Many
studies which comprise global miRNA detection and quantifi-
cation rely on oligo microarray-based methods (microarray
technology) [2,3]. Microarray methods have the advantage of
being relatively low cost (reviewed in [4]), relatively quick from
RNA labeling to data generation and simple to use [5]
compared to e.g. ultra high-throughput sequencing technologies.
MicroRNA microarray results are similar to mRNA expression
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profiling results most commonly validated by RT-qPCR which
is referred to as ‘gold-standard’ for holistic relative miRNA
quantification [6]. PCR-based platforms for miRNA expression
profiling, which combine simultaneous analysis of a large
number of targets in a single experiment and advantages of
qPCR, are of high interest and very effective.
Unlike for mRNA expression microarrays, comprehensive
quality control and standardization studies [7] are rather limited
for microRNA microarrays. Furthermore, the usual assumptions
employed for mRNA expression array normalization may not
hold true for miRNA arrays as summarized by Sarkar et al. [8].
Studies addressing intra-platform repeatability and inter-plat-
form comparability of different miRNA microarray platforms
[9] or microarray versus RT-qPCR profiling platforms [3,10]
are rare. However, selection of normalization methods for
miRNA microarrays can have effects on resulting data outcome
[8,11–13] and physiological interpretation as adequate normal-
ization methods can minimize the effects of systematic
experimental bias and technical variations (reviewed in [14]).
Optimal normalization of miRNA data may even be more
critical than that of other RNA functional classes since relatively
small changes in miRNA expression may be biologically and
clinically significant [15,16]. Moreover, the recently defined
MIQE guidelines for quality control and standardization of RT-
qPCR experiments [17] imply the use of the optimal
normalization method. There is no clear consensus on the
relative performance of normalization methods for miRNA
profiling data as results and recommendations from previous
studies have been inconsistent [18,19]. Further comparative
studies providing guidance or suggestions of adequate normal-
ization to the community are needed to facilitate the application
of adequate miRNA normalization methods and provide an
estimate for cross-platform comparisons.
Thus, the objective of this study was to investigate the impact
of normalization methods on intra- and inter-platform perfor-
mance of distinct miRNA profiling approaches. We hypothe-
sized that selection of an appropriate normalization method
could minimize standard deviations, increase sensitivity, and
cross-platform similarity of miRNA expression and thus increase
intra- and inter-platform comparability and validity.
This study evaluated the impact of normalization strategies
on a hybridization-based platform from Agilent Technologies
(Santa Clara, USA) (AGL array) and a multiplex/megaplex RT-
qPCR platform from Applied Biosystems (Foster City, USA)
(TLDA) relative to singleplex RT-qPCR (Figure 1). We utilized
normalization methods commonly used in one-color miRNA
microarray or RT-qPCR profiling studies (reference gene index
(RGI), global geometric mean (geomean), quantile, invariant
selection (INV), loess [12,20,21], respectively, and adapted the
LoessM normalization [11] and the assumption-free general
procrustes analysis (GPA) [22] to one-color miRNA profiling
platforms. The biological effect of cell differentiation and
cytokine treatment on miRNA expression implemented the
basis for inter- and intra-platform assessments. Patient derived
primary human skeletal myoblasts and the murine skeletal
muscle cell line PMI28 were cultured as undifferentiated
myoblasts, differentiated myotubes and myotubes which had
been treated with TNF-a in vitro. Thus, we could provide a
comparative study of the impact of normalization methods over
three different biological backgrounds, two species, and two
profiling platforms (Figure 1).
Results and Discussion
Intra-platform Identification and Concordance of
Differential miRNA Expression Depended on the
Normalization Method
Both, oligonucleotide hybridization-based and RT-qPCR-based
techniques are widely used for miRNA expression profiling.
Considerable effects of normalization on the detection of
differentially expressed genes have been reported for one- and
dual-channel miRNA microarrays [9,11]. Therefore, one objective
of this study was to compare and evaluate the impact of RGI,
geomean, quantile, INV, loess, loessM, and GPA normalization
strategies on AGL array and TLDA data. We investigated the
reduction of bias, the quality (diagnostic performance of the test)
and quantity in identifying differentially expressed miRNAs as well
as the dissimilarity of datasets after normalization.
Qualitative and quantitative effects of distinct
normalization methods on the identification of differential
miRNA expression within platforms. We assume that a good
normalization method should minimize the effects of systematic
experimental and technical bias as well as reduce the variance
between replicates. Signal distributions within Agilent arrays and
TLDA cards were more similar after normalization compared to
the non normalized datasets (Figure 2 and 3). The mean inter-
replicate standard deviations of the three biological treatment
groups and two different species were reduced by all normalization
methods applied (Table 1 and 2). For the Agilent platform loess
and loessM were most effective in reducing intra-group variation
followed by INV, quantile, and GPA normalization. TLDA
profiling revealed the least variation between replicates for loessM
normalization followed by loess, quantile, and GPA normalization.
Quantile normalization of TLDA data was reported to be more
effective in reducing standard deviations than geomean normal-
ization [23] which is in line with our data.
Moreover, we evaluated the impact of different normalization
methods on sensitivity and specificity using the receiver operating
characteristic (ROC) curve which is a plot of sensitivity (true
positive rate) versus the formula 1 - specificity (or false positive
rate). The area under the ROC curve (AUC) can be interpreted as
a summary index of classification performance [24] between
biological groups since it is a threshold independent global
performance measure [25]. The effectiveness in distinguishing true
differential expression due to myoblast differentiation or TNF-a
treatment in human and mouse was best for loess, loessM, GPA,
and INV normalization on both profiling platforms, AGL array
and TLDA, as indicated by the mean AUC (Table 3 and 4). Based
on the mean AUC, RGI normalization as well as geomean and
quantile normalization turned out to be inferior in retaining
treatment effects on the AGL array platform. Taken together,
loess, loessM, GPA, and INV normalization robustly maximized
sensitivity and specificity of classification in contrary to quantile
normalization which was effective in the reduction of bias only. In
line with our results Risso et al. [11] showed that loessM, GPA,
and loessM combined with GPA outperformed quantile normal-
ization in terms of sensitivity and specificity.
Our study indicates, that normalization methods which turned
out to increase the area under the ROC curve most effectively
(loess, loessM, GPA, INV) resulted in an increase of significantly
expressed miRs compared to no normalization for AGL array
derived data (Table 5) and a reduction on TLDA derived data
(Table 6), respectively. Latter illustrated that accumulation of
systematic experimental or technical bias within replicates can
either amplify or mask differential expression depending on the
direction of regulation. Thus, applying normalization increase or
MiRNA Profiling Platforms and Their Normalization
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decrease the dynamic (compare Figure S1) and significance of
differential expression (Table 5 and 6). Interestingly, RGI
normalization revealed the highest number of differentially
expressed miRs on both platforms and a comparatively small
area under the ROC curve. The trade-off between the true
positive rate and specificity points to why superior normalization
methods do not necessarily increase the amount of differentially
expressed genes. At the same time the optimal normalization
strategy for a platform’s dataset should yield a reasonable number
of differentially expressed miRNAs since an overly aggressive
normalization technique would cause an ‘‘averaging-out’’ effect
[26].
The impact of normalization methods on the detection of
differential expression was further evaluated by utilizing the
Jaccard index [27] as similarity measure of differentially expressed
gene lists. The non normalized datasets of the Agilent microarray
and TLDA platform showed the tendency to reveal dissimilarity to
the corresponding normalized datasets (Table 7 and 8, Figure S2
and S3) which is consistent with a general impact of normalization
on data distribution, variance and detection of differential
expression as discussed above. In the case of the AGL array,
loess, loessM, GPA, and INV normalized datasets tended to show
similarity in the detection of differentially expressed miRs (Table 7
and 8). The qPCR profiling platform revealed similarity among
loess, loessM, GPA, and quantile normalized data. Thus,
algorithms such as loess or loessM which are capable of removing
intensity-dependent bias and the assumption free GPA algorithm
robustly optimized datasets derived from Agilent microarrays and
TLDA cards. Results from our study suggest that INV normal-
ization performs better than quantile, RGI or geomean normal-
ization on the Agilent microRNA platform. Pradervand et al. [12]
suggested that normalization based on the set of invariants or
quantile were more robust than e.g. scaling. Our study revealed
that quantile normalization performed acceptable well for TLDA
profiling data. However, we cannot confirm that quantile is one of
the most robust normalization strategies as suggested by Rao et al.
[26] and Zhao et al. [19] for miRNA microarrays.
Finally, geomean or RGI normalization did not perform
acceptable well neither on the microarray nor on the qPCR
platform. Our data exemplifies that less sophisticated methods like
geomean or RGI normalization which can only correct for ‘global
multiplicative effects’ might not be sufficient for miRNA profiling
data.
Assessment of assumptions underlying distinct
normalization methods. The adequacy of normalization
approaches might depend on whether the datasets meet the
assumptions which underlie the respective algorithms. Normali-
zation methods such as quantile and loess are based on two
assumptions, (i) only a small portion of miRNAs is differentially
expressed, and (ii) differentially expressed spots are homogeneously
distributed with respect to both, over- and under-expressed
miRNAs [11]. However, these assumptions could fail for miRNA
profiling data [11,13]. Since the number of expressed miRNAs in
a given sample tends to be much smaller than that observed when
profiling mRNA expression the proportion of those that are
differentially expressed (among those expressed at all) is much
larger compared to mRNA [8]. We verified whether the above
assumptions hold true for our datasets. In this study 44.4%
(162 miRNAs) human and 70.1% (410) rodent miRNAs of the
theoretically detectable miRNAs within the TLDA platform
passed the quality control criteria and were considered as
successfully detected. The AGL array platform detected 37.8%
(302 miRNAs) human and 40.5% (282) murine miRNAs of the
theoretically detectable miRNAs. On average, 26.3% of the
expressed miRNAs were differentially regulated within the AGL
array data and 13.0% within the TLDA card data during
myoblast differentiation and cytokine treatment in human and
mouse. Thus, the proportion of differentially regulated miRNAs is
Figure 1. Platforms and normalization methods applied. Overview of intra- and inter-platform comparisons using miRNA microarrays from
Agilent Technologies (AGL Array) and RT-qPCR arrays from Applied Biosystems (TLDA) for human and mouse miRNAs as well as singleplex TaqMan
miRNA assays. Different normalization methods were applied to the platforms. Three distinct biological stages of mouse and primary human skeletal
cells were analyzed.
doi:10.1371/journal.pone.0038946.g001
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in the range revealed by other miRNA profiling studies and less
than 50% as summarized in Rao et al. [26]. However, even if one
would expect a significant fraction to be differentially expressed
INV normalization is particularly appropriate since INV-based
regression assumes that there is a subpopulation of expressed genes
that does not change [12]. Furthermore, the assumption of
symmetry of differentially expressed miRNAs was investigated.
Symmetry of up- and down-regulations for the human and murine
samples was overall balanced across normalization methods and
the non-normalized dataset as reflected by a mean of log2
regulations close to zero namely 0.0760.22 (differentiation) and
20.1860.26 (cytokine treatment) on AGL array platform and
overall symmetry on the TLDA platform with a mean Cq
regulation of 0.2960.3 upon differentiation and 0.1260.51 due to
the effect of cytokine treatment. Moreover, normalization
strategies such as loessM do not depend on the assumptions that
there exists only a small proportion of differentially expressed
miRNAs and the distribution of differential miRNA expression is
symmetrical between over and under expressed [11]. Finally, GPA
is an assumption free approach [22]. Quantile normalization
assumes that the overall distribution of signal intensity does not
change which is the case for AGL array data as well as TLDA data
in this study (Figure 2 and 3). Generally speaking, all normaliza-
tion methods applied within this study were applicable for the
datasets presented here and should be compatible for the vast
majority of studies using one-color hybridization or RT-qPCR
based miRNA profiling platforms.
Platform-specific Selection of Normalization Strategies
can Maximize Inter-Platform Concordance of Differential
miRNA Expression
The confirmation of differential expression by independent and
rather different profiling approaches is of particular interest in
miRNA research. Since comparatively small changes in miRNA
expression might be of physiological relevance the verifiability of
miRNA expression across platforms is a useful approach to get a
first estimate of the biological importance. To evaluate inter-
platform concordance of relative miRNA expression we investi-
gated subsets of 127 miRNAs from human and 201 miRNAs from
mouse samples which contained all miRNAs successfully detected
by both, AGL array as well as TLDA platform.
Intra-platform performance of normalization methods
was confirmed for the platform overlapping miRNA
subset. The impact of different normalization methods on the
quality and quantity of differential expression within the miRNA
overlapping subsets was evaluated. Thereby we wanted to exclude
the effect of a putative subset specific performance of normaliza-
tion methods. We could confirm similar tendencies of normaliza-
tion performance measures in the platform overlapping number of
miRNAs (common inter-platform subset) compared to the
observations for the platform specific miRNA subset described
above. Standard deviations of the six biological groups (three
human and three mouse groups) were reduced by all normaliza-
tion methods applied (Table S1 and S2) compared to the non
normalized datasets. The reduction of standard deviations on the
Agilent platform was most evident for loess and loessM. Moreover,
INV, quantile, RGI, and GPA normalization were effective in
alleviating standard deviations. Variation within the TLDA
platform was lessened most by loessM normalization followed by
loess, quantile, and GPA normalization. The overall sensitivity and
specificity in detection of differential gene expression was best for
loess, loessM, GPA, and INV normalized Agilent microarray and
TLDA data. Loess, loessM, GPA, and INV normalization shifted
the trade-off between true positive rate and false positive rate
towards higher mean AUCs (Table 9 and 10). The numbers of
significantly regulated miRNAs were similarly influenced by the
normalization approaches (Table S3 and S4) as described for the
platform-specific datasets. Since the stability of lowess smoothers is
known to be dependent on the number of data points to which
they are applied [19] it is worth noting that loess and loessM seem
to robustly improve data quality on different sizes of datasets (as
shown for the platform-specific as well common miRNA subset).
In concert with the platform-specific data, results from the
platform-shared miRNA sets underscore the importance of
adequate evaluation and selection of the normalization method
which had distinct impact on the quantity and accuracy of
differential miRNA expression.
Influence of distinct normalization methods on inter-
platform concordance of differential miRNA
expression. Validation of miRNA microarray data by an
independent method such as qPCR has been widely used and
accepted as gold standard. However, platform-specific bias and
performance characteristics might impact consistency across
platforms. We propose that adequate platform-specific normali-
zation methods could maximize inter-platform concordance of
differential miRNA expression. Inter-platform similarity of
miRNA expression regulation was evaluated by calculating the
Jaccard indices between platforms and corresponding normaliza-
tion approaches (Table 11, Figure S4) for the common miRNA
subset. The comparison of Jaccard indices for myoblast differen-
tiation and cytokine treatment in human and mouse showed a
tendency of loess, loessM, quantile, and GPA normalization of
AGL data to increase similarity across platforms. For the TLDA
derived data the results of similarity analysis indicate that loess,
loessM, geomean and RGI increased consistency and reproduc-
ibility of differentially expressed miRNAs across platforms. The
following combinations substantially increased inter-platform
concordance of differential expression as listed in descending
order: AGL-non with TDLA-non, AGL-GPA with TLDA-geom,
AGL-loess/loessM with TLDA-loess/loessM, AGL-quant with
TLDA-RGI (Table 11). Based on the Jarrad index the least inter-
platform concordance was achieved among RGI normalized
Agilent data and INV normalized TLDA data. Comparatively
high Jaccard indices between the non normalized datasets of
Agilent microarray and non normalized TLDA cards might be
explained by the similar number of differentially expressed
miRNAs (Table S3 and S4). As the Jaccard index gives the
intersection of differentially expressed miRNA lists relative to the
union of the miRNA lists the divisor in this calculation is
comparatively small for the non normalized datasets giving a high
similarity measure. However, the absolute number of miRNAs
consistent between the non normalized data is smaller on average
compared to the list overlap of normalized datasets (Figure S5).
Hence, adequate selection of normalization methods such as loess
or loessM could increase the similarity of inter-platform validated
miRNAs. Geomean normalization of TLDA data showed the
tendency to increase inter-platform concordance, but on the basis
of our intra-platform data we can favour geomean normalization
Figure 2. Signal distribution of human microarray and qPCR profiling. Box-whisker plot with 5th and 95th percentiles (black dots) of log2-
transformed human AGL array signals or Cq values of human TLDA platform were shown for nine samples each across different normalization
techniques.
doi:10.1371/journal.pone.0038946.g002
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for TLDA profiling data only when cross-platform validation is
available to avoid false positives. Interestingly, the subset of
differentially expressed miRNAs which were reproducibly identi-
fied across normalized platforms included miRNAs that had been
functionally validated to play a role in skeletal muscle [28,29].
Taken together, our data underscores that adequate normalization
can increase inter-platform comparability and validity. Thus,
normalization might be an important adjustable factor in the
verifiability and consistency of miRNA expression across plat-
forms.
Adequate Normalization of Profiling Data Yields Good
Verifiability by Singleplex Assays
Individual RT-qPCR assay analysis validated inter-
platform concordance of differential expression. We pro-
pose that adequate normalization of miRNA profiling data yields
good verifiability by individual qPCR assays. Hence, we selected
differentially expressed miRNAs (p,0.05) of the loessM-normal-
ized common subset of human miRNAs on AGL array and TLDA
and evaluated expression by individual assays for myoblast
differentiation (Figure 4 A) and cytokine treatment effect
(Figure 4 B). Inter-platform concordance of significantly regulated
miRNAs was validated in the majority of cases (Figure 4 A miR-II
to -V and 4 B miR-II, -IV, -V). Furthermore, miRNAs which were
not significantly regulated on either of the platforms could be
confirmed by individual assays as well (Figure 4 A miR-VI to -IX,
4 B miR-VIII, -IX). Correlation coefficients of individual assays
and loessM normalized AGL array as well as TLDA were
considerable high (Spearman’s R= 0.875, p,0.01) validating
inter-platform concordance of differential expression.
Platform-specific Characteristics of Datasets
Inter-platform differences of variability and dynamic of
differential expression. The total number of differentially
expressed miRNAs was larger for AGL arrays than for TLDA
even if the same miRNA subsets were observed (Table S3 and S4).
In general one would rather expect the RT-qPCR system to reveal
a higher number of differential expressions due to high sensitivity
of the system and template amplification of qPCR. However, the
higher overall miRNA expression standard deviation of
0.63560.112/0.41360.070 (loessM normalized platform specif-
ic/common dataset) compared to AGL array with an average
standard deviation of 0.17360.061/0.13760.077 (loessM nor-
malized platform specific/common dataset) indicated that qPCR
was associated with the amplification of bias as well. Moreover, the
comparison of fold-changes indicated a compression of fold-
change dynamic for the AGL array (Figure S1) compared to
TLDA which is in line with results from Pradervand et al. (2009).
Compression of differential gene expression across platforms was
indicated by linear regression with a slope of 0.302/0.632
(human/mouse) for myoblast differentiation and 0.352/0.233
(human/mouse) for TNF-a treatment (Figure S6). However,
comparison of t-values illustrated a compression of t-values for
the TLDA platform compared to AGL array with a slope of
20.181/20.375 (human/mouse) for myoblast treatment and
20.121/20.414 (human/mouse) for TNF-a treatment (Figure
S7). Hence, we might conclude that in our study the AGL array
identified more differentially expressed genes due to less variance.
Generally speaking, inter-platform similarity was rather low which
is in line with a study by Chen et al. [3] reporting considerable
variability between miRNA microarray and TLDA data indicated
by low correlation between the two methods.
Summary and Conclusions
This is the first comparative study evaluating the impact of RGI,
geomean, INV, quantile, loess, loessM, and GPA normalization
methods on intra-platform performance as well as inter-platform
comparability of two commonly used platforms, a one-color
hybridization-based Agilent microarray versus an RT-qPCR
miRNA profiling platform from Applied Biosystems. We used
mouse and human samples and validated profiling results by
individual miRNA RT-qPCR assays. In summary, normalization
reduced inter-replicate standard deviations and affected differen-
tial miRNA expression detection. Normalization methods like
loess, loessM, GPA, and INV which increased sensitivity of
Figure 3. Signal distribution of mouse microarray and qPCR profiling. Box-whisker plot with 5th and 95th percentiles (black dots) of log2-
transformed mouse AGL array signals or Cq values of mouse TLDA platform were shown for nine samples each across different normalization
techniques.
doi:10.1371/journal.pone.0038946.g003
Table 1. Mean inter-replicate variance was minimized by
applying normalization methods to the AGL array.
Normalization mean ± sdev
RGI 0.183 0.064
Geom 0.204 0.073
Quantile 0.176 0.059
INV 0.176 0.059
Loess 0.173 0.061
LoessM 0.173 0.061
GPA 0.178 0.056
Non 0.320 0.163
Agilent - Intra-platform.
Standard deviation.
The average of intra-replicate standard deviations in human and mouse
myoblasts, myotubes, and cytokine treated myotubes based on the platform-
specific miRNA datasets were depicted. The mean intra-platform standard
deviations depended on the normalization method.
doi:10.1371/journal.pone.0038946.t001
Table 2. Mean inter-replicate variance was minimized by
applying normalization methods to TLDA cards.
Normalization mean ± sdev
RGI 0.662 0.119
Geom 0.651 0.126
Quantile 0.642 0.118
INV 0.696 0.220
Loess 0.636 0.115
LoessM 0.635 0.112
GPA 0.650 0.124
Non 0.738 0.166
TLDA - Intra-platform.
Standard deviation Legend information as specified for Table 1.
doi:10.1371/journal.pone.0038946.t002
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classification did not maximize the number of differentially
expressed miRNAs. Furthermore, the intra-platform performance
of normalization methods was confirmed for the platform
overlapping miRNA subset. In general, selection of the profiling
platform affected the variability and dynamic of differential
miRNA expression. However, the platform-specific selection of
normalization strategies could maximize consistency and repro-
ducibility of differential miRNA expression detection across
profiling platforms and yielded good verifiability by singleplex
qPCR assays. To put it in a nutshell, the choice of the
normalization strategy had a qualitative and quantitative impact
on the identification of differential miRNA expression and could
contribute to the adjustment of platform-specific performance
differences.
In conclusion, we recommend the application of loess, or
loessM, and GPA normalization for miRNA Agilent hybridization
arrays and qPCR TLDA cards. Loess, loessM, and GPA
normalizations showed to (i) effectively reduce standard deviations,
(ii) increase sensitivity and accuracy of differential miRNA
expression detection as well as (iii) increase inter-platform
concordance. This study showed the successful adoption of loessM
and GPA to one-color miRNA profiling experiments. Our results
provide an additional piece of evidence that the choice of the
normalization algorithm and profiling platform has a profound
effect on determining differential miRNA expression and we
encourage researchers to evaluate the sensitivity of their data to
different assumptions and algorithms.
Materials and Methods
Cell Culture
Primary human skeletal muscle cells (hSkMCs) were obtained
from the ‘‘Muscle Tissue Culture Collection’’ at the Friedrich-
Baur-Institute (LMU, Munich, Germany), and were propagated
in skeletal muscle cell growth medium low serum (PromoCell)
supplemented with 10% fetal calf serum (FCS) (PAA Labora-
tories), and 2 mM L-glutamine (PAA Laboratories). The murine
skeletal myoblast cell line PMI28 [30] was cultured in Ham’s
F10 (PAA Laboratories), supplemented with 20% FCS (Sigma-
Aldrich), 2 mM L-glutamine (PAA Laboratories), and 1%
Penicillin/Streptomycin (PAA Laboratories). Myoblasts were
propagated at 37uC in humidified air (80% relative humidity)
and 5% CO2. Human and murine myoblasts were cultured on
laminin-1 coated dishes for an additional 24 h before switching
a fraction of dishes to differentiation medium (DMEM medium
containing 2% horse serum (Gibco), 2 mM L-glutamine (PAA
Laboratories), and 0.1% gentamicin (Gibco) (human myoblasts)
or 1% Penicillin/Streptomycin (murine myoblasts)) with
26103 U/ml human recombinant TNF-a (Roche Applied
Science) or 26103 U/ml murine recombinant TNF-a (Roche
Applied Science) or carrier, respectively. All media were
replenished twice a day. hSkMCs and pmi28 cells were
harvested 24 h after the induction of fusion by serum
withdrawal.
Total RNA Preparation
Human cell pellets were lysed and homogenized with Qiazol
(Qiagen) and total RNA was extracted using the RNeasy Mini
Kit (Qiagen) according to the manufacturer’s instructions.
Murine cells were lyzed in Trizol (Invitrogen) and total RNA
was prepared according to the manufacturer’s instructions.
Total RNA concentrations were determined photometrically
using the NanoDrop 1000 ND-1000 (Peqlab). RNA quality was
characterized using the 2100 Bioanalyzer (Agilent Technologies)
[24]. Samples yielded high RNA quality (RIN values between 8
and 10) and were further processed for profiling or individual
qPCR analyses.
Table 3. Mean area under the ROC curve of AGL arrays.
Normalization AUC mean ± sdev
Loess 0.912 0.079
LoessM 0.912 0.079
Quantile 0.899 0.074
INV 0.908 0.082
GPA 0.911 0.077
RGI 0.872 0.111
Geom 0.886 0.110
Non 0.905 0.113
Agilent - Intra-platform.
ROC curves The average of the AUCs of ROC analyses in human and mouse
myoblast differentiation and cytokine treatment were illustrated based on the
platform-specific miRNA sets. The mean AUC was influenced by normalization
algorithms.
doi:10.1371/journal.pone.0038946.t003
Table 4. Mean area under the ROC curve of TLDA cards.
Normalization AUC mean ± sdev
Loess 0.861 0.154
LoessM 0.861 0.154
Quantile 0.856 0.155
INV 0.889 0.122
GPA 0.884 0.126
RGI 0.856 0.161
Geom 0.858 0.146
Non 0.841 0.170
TLDA - Intra-platform.
ROC curves Legend information as specified for Table 3.
doi:10.1371/journal.pone.0038946.t004
Table 5. Effect of normalization methods on the number of
differentially expressed miRNAs detected by AGL arrays.
Normalization signifcant miRNAs ± sdev
RGI 83 38
Geom 72 35
Quantile 81 37
INV 81 37
Loess 81 37
LoessM 81 37
GPA 79 36
Non 54 31
Agilent - Intra-platform.
Significant miRNAs The mean number of differentially expressed miRNAs
which were identified in distinctively normalized human and mouse myoblast
differentiation and cytokine treated samples were depicted.
doi:10.1371/journal.pone.0038946.t005
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MiRNA Microarray Analysis
MicroRNA expression profiling of myoblasts, myotubes and
cytokine treated myotubes with three cell culture replicates per
groups was performed by using an oligonucleotide hybridization-
based platform from Agilent Technologies. Human samples were
analyzed with the Human MicroRNAMicroarray V2 (AGL array)
containing probes for 723 human and 76 human viral miRNAs
from Sanger miRBase 10.1. Murine samples were profiled with
Mouse miRNA Microarray Release 15.0 containing probes for
696 miRNAs from Sanger miRBase release 15.0. We used 100 ng
total RNA per sample and microarray. Labeling and hybridization
was performed according to the manufacturer’s instructions.
Resultant data from AGL arrays were extracted from image files
and log2-transformed utilizing the Feature Extraction Software
(Agilent Technologies). For further analysis only those miRNAs
which showed a signal greater than zero in at least two of the three
cell culture replicates within a group were retained thereby leaving
302 miRNAs for human and 282 miRNAs for murine samples.
Different normalization approaches were applied (see section
‘‘Normalization’’ further below). All Agilent microarray data were
MIAME compliant and were registered into ArrayExpress
database [31], a publicly available repository consistent with the
MIAME guidelines. Data are available with the following
ArrayExpress accession numbers E-MTAB-299 (human dataset)
and E-MTAB-1114 (mouse dataset).
MiRNA RT-qPCR Profiling
The TaqMan Array Human MicroRNA Panel 1.0 (Applied
Biosystems) (based on Sanger miRBase 9.2) facilitated the specific
amplification and detection of 365 different mature human
microRNAs by TaqMan-based quantitative real-time PCR in a
384-well or TaqMan Low Density Array format (TLDA).
Outlining the experimental procedure, for each sample and plate
eight separate multiplex reverse transcription (RT) reactions
(Human Multiplex RT Set Pools 1–8) were performed with
50 ng total RNA each. Stem-loop structured RT primers allowed
for the specific RT of mature miRNAs with single-base
discrimination [32]. The resulting cDNA was loaded into the
arrays and TaqMan real-time PCR was performed using the
7900 HT Fast Real-Time PCR System (Applied Biosystems) with
cycling conditions according to the manufacturer’s protocol.
150 ng total RNA of murine pmi28 samples were reverse
transcribed and preamplified using the MegaPlex Rodent Primer
Pool Set (Life Technologies) according to the manufacture’s
instructions. Preamplified samples were profiled with the TaqMan
Rodent MicroRNA Arrays 2.0 (Life Technologies) including
primers for 585 different mature miRNA. All samples analyzed by
the Agilent platform were included in the TLDA analyses. TDLA
profiling was conducted at IMGM Laboratories GmbH on
Applied Biosystems 7900 HT Fast Real-Time System with cycling
conditions according to the manufacturer’s instructions. Raw data
was obtained using SDS 2.3 software (Applied Biosystems). All
SDS files were analyzed utilizing the RQ Manager 1.2 software
(Applied Biosystems). miRNAs meeting the detection criterion of
showing Cq-values smaller 35 (human samples) or 32 (murine
samples) in at least two of the corresponding triplicates of a group
(as recommended by the vendor) were retained for further data
processing. For the human and the murine samples each, a
common subset of miRNAs passing pre-processing procedure on
both, the AGL array and the TLDA platform, was identified based
on nomenclature and/or sequence identity giving rise to a set of
127 human miRNAs and a common subset of 201 miRNAs for
the mouse cells. Data was normalized as described in section
‘‘Normalization’’.
Validation of miRNA Profiling with RT-qPCR
Selected miRNAs were analyzed in myoblasts (n = 4), myotubes
(n = 3) and myotubes treated with TNF-a (n = 3) using individual
TaqMan MicroRNA Assays and reverse transcription reagents
from Applied Biosystems according to the manufacturer’s instruc-
Table 6. Effect of normalization methods on the number of
differentially expressed miRNAs detected by TLDA cards.
Normalization signifcant miRNAs ± sdev
RGI 47 28
Geom 42 26
Quantile 37 30
INV 21 11
Loess 38 29
LoessM 38 29
GPA 31 20
Non 44 36
TLDA - Intra-platform.
Significant miRNAs Legend information as specified for Table 5.
doi:10.1371/journal.pone.0038946.t006
Table 7. Impact of normalization strategies on the similarity of differential miRNA expression of AGL array data.
Loess LoessM Quantile INV GPA RGI Geom Non
Loess 1
LoessM 1 1
Quantile 0.681 0.681 1
INV 0.815 0.815 0.652 1
GPA 0.787 0.787 0.725 0.742 1
RGI 0.652 0.652 0.638 0.669 0.723 1
Geom 0.576 0.576 0.555 0.547 0.635 0.631 1
Non 0.397 0.397 0.340 0.408 0.355 0.303 0.303 1
Agilent - Intra-platform Jaccard index The mean Jaccard indices of significantly regulated miRNA overlap across normalized datasets were depicted for myoblast
differentiation and cytokine treated samples analyzed of human and mouse. The Jaccard index ranges between zero and one per definition. The closer the Jaccard
index is to one the higher the relative similarity and reproducibility of differential expression across platforms.
doi:10.1371/journal.pone.0038946.t007
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tions. Validation of microRNA profiling data by individual assays
was performed in quadruplicate reverse transcription reactions
and qPCR reactions for each cell culture replicate. MiRNAs
selected for validation include three miRNAs with expression
values corresponding to the median value of not normalized
human TLDA data of myotubes. Two of these miRNAs with
expression values consistent with the median were identified to be
stably expressed by geNorm [33] analysis of TLDA data.
Furthermore, a significantly regulated miRNA with expression
levels below the median was included as well as five significantly
regulated miRNAs (both, during differentiation and cytokine
treatment or as response to cytokine treatment only) with
expression values higher than the median. Most of the selected
miRNAs corresponded to candidates in the upper half of
expression values because significantly, and thus biologically
interesting miRNAs, were identified primarily in the mentioned
expression range.
Normalization
We used seven different methods (RGI, geomean, quantile, INV,
loess, loessM und GPA) to normalize the data. Since there is no gold
standard for miRNA normalization, yet, we worked with all seven
methods. The arithmetic mean of two stably expressed miRNAs as
identified by GeNorm [33] or Normfinder [34] served as reference
gene [35] index. Furthermore, the global geometric mean of all
expressed miRNAs in one sample [20] which met the detection
criteria was used for normalization. The standard normalizations
quantile and loess are described by Bolstad et al. [21] and the
invariant selection was introduced by Pradervand et al. [12]. For
the loessM normalization we adapted the method of Risso et al.
[11]. In order to avoid small values close to 0 the median of the
respondent value in the loess estimation is added to the dataset. This
modification relaxes the assumption of symmetry among up- and
down-regulated genes [11]. Since this intra-array normalization
method is normally used with two dimensional arrays (green and
red signal) we adopted the method for our one dimensional arrays.
A brief description and the corresponding R code can be found in
the Technical Appendix and http://www.statistik.lmu.de/,kaiser/
sup-material.html, respectively. LoessM normalization was applied
since it is an assumption-free inter-array method. The same
problem arose in the Generalized Procrustes Analysis (GPA). Since
Xiong et al. [22] used the GPA for their two-dimensional red and
green signal intensities we used the GPA on the three Groups (MB,
MT,MT+TNF) of arrays instead. A detailed description and code is
enclosed in the Technical Appendix and http://www.statistik.lmu.
de/,kaiser/sup-material.html, respectively. We utilized GPA
normalization since it is an assumption-free inter-array method.
The following normalizations were done in R [36] using the
functions: normalize.quantiles (package preprocessCore, Biocon-
ductor [37]), normalize.loess (package affy, Bioconductor [37]),
normalize.loessM (own code, http://www.statistik.lmu.de/
Table 8. Impact of normalization strategies on the similarity of differential miRNA expression of TLDA card data.
Loess LoessM Quantile INV GPA RGI Geom Non
Loess 1
LoessM 1 1
Quantile 0.723 0.723 1
INV 0.598 0.598 0.513 1
GPA 0.741 0.741 0.677 0.597 1
RGI 0.557 0.557 0.524 0.408 0.526 1
Geom 0.680 0.680 0.606 0.495 0.691 0.596 1
Non 0.560 0.560 0.476 0.468 0.520 0.425 0.421 1
TLDA - Intra-platform Jaccard index Legend information as stated for Table 7.
doi:10.1371/journal.pone.0038946.t008
Table 9. Mean area under the ROC curve of the inter-
platform miRNA subsets for AGL arrays.
Normalization AUC mean ± sdev
Loess 0.923 0.080
LoessM 0.923 0.080
Quantile 0.903 0.069
INV 0.919 0.086
GPA 0.915 0.084
RGI 0.875 0.148
Geom 0.899 0.098
Non 0.902 0.121
Agilent - Inter-platform.
ROC curves The average of the AUCs of ROC analyses in human and mouse
myoblast differentiation and cytokine treatment were shown for the miRNA
subset shared by both platforms. The mean AUC was influenced by
normalization algorithms similar to the platform-specific dataset.
doi:10.1371/journal.pone.0038946.t009
Table 10. Mean area under the ROC curve of the inter-
platform miRNA subsets for TLDA cards.
Normalization AUC mean ± sdev
Loess 0.921 0.094
LoessM 0.921 0.094
Quantile 0.903 0.102
INV 0.920 0.116
GPA 0.923 0.092
RGI 0.912 0.094
Geom 0.910 0.095
Non 0.909 0.138
TLDA - Inter-platform.
ROC curves Legend information as stated for Table 9.
doi:10.1371/journal.pone.0038946.t010
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,kaiser/sup-material.html, Technical Appendix), invariant_
selection.R (Supporting information of [12]), normalize.GPA
(modified procGPA function from package shape, http://www.
statistik.lmu.de/,kaiser/sup-material.html, Technical Appendix).
Table 11. Inter-platform concordance of differential expression and its dependency on normalization methods.
TLDA AGL
Loess LoessM Quantile INV GPA RGI Geom Non
Loess 0.292 0.292 0.280 0.271 0.282 0.230 0.268 0.272
LoessM 0.292 0.292 0.280 0.271 0.282 0.230 0.268 0.272
Quantile 0.270 0.270 0.266 0.259 0.280 0.229 0.253 0.269
INV 0.218 0.218 0.212 0.198 0.213 0.174 0.181 0.267
GPA 0.260 0.260 0.267 0.244 0.275 0.210 0.248 0.246
RGI 0.276 0.276 0.288 0.257 0.282 0.227 0.240 0.245
Geom 0.285 0.285 0.279 0.259 0.296 0.237 0.271 0.242
Non 0.242 0.242 0.224 0.229 0.235 0.176 0.223 0.331
Agilent and TLDA - Inter-platform Jaccard index The average Jaccard indices of significantly regulated miRNA overlap across human and mouse AGL array and
TLDA was depicted for the miRNA subset shared by both platforms. The closer the Jaccard index is to one the higher the relative similarity and reproducibility of
differential expression across platforms.
doi:10.1371/journal.pone.0038946.t011
Figure 4. Differential expression detected by three different miRNA analysis approaches. Concordance and validation of DDCq or
DDlog2 values, respectively, of three different human miRNA analysis methods: Singleplex RT-qPCR assay (RGI), AGL array (loessM), and TLDA
(loessM). The effect of myoblast differentiation (A) and cytokine treatment (B) was investigated. Significant miRNA regulations were indicated by
asterisks. Nine human miRNAs were represented by Latin numbers I–IX (see materials and methods for more detailed information).
doi:10.1371/journal.pone.0038946.g004
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Statistics
Significance of relative quantification [38] of miRNA expression
levels was determined by applying significance analysis of
microarrays (SAM) [39], an assumption free approach adopted
to microarray. SAM identifies differentially expressed miRNAs by
permutation.
Supporting Information
Figure S1 Fold-change distribution. Distribution of fold-
changes of human and mouse AGL microarray and TLDA
platform data during myoblast differentiation and cytokine
treatment were illustrated by box-whisker plots with 5th and 95th
percentiles (black dots). Fold-change distribution of RGI, geo-
mean, quantile, INV, loess, loessM, and GPA normalized and the
non-normalized datasets were depicted.
(TIF)
Figure S2 Human heatmap of relative similarity in
detecting differential expression within distinctively
normalized datasets. Jaccard indices of significantly regulated
miRNA overlap between distinctively normalized datasets were
depicted for myoblast differentiation and cytokine treated samples
analyzed on human AGL array or TLDA card. Colour coding of
the heatmap was gradually from red indicating low similarity to
white indicating a Jaccard index close to one.
(TIF)
Figure S3 Mouse heatmap of relative similarity in
detecting differential expression within distinctively
normalized datasets. Jaccard indices of significantly regulated
miRNA overlap between distinctively normalized datasets were
depicted for myoblast differentiation and cytokine treated samples
analyzed on mouse AGL array or TLDA card. Colour coding of
the heatmap was as stated in Figure S2.
(TIF)
Figure S4 Heatmap of relative inter-platform similarity
in detecting differential expression dependent on the
normalization applied. Jaccard indices of significantly regu-
lated miRNA overlap across the two distinctively normalized
platforms, AGL array and TLDA card, were depicted as heatmap
for myoblast differentiation and cytokine treated samples. Colour
coding of the heatmap was as stated in Figure S2.
(TIF)
Figure S5 Inter-platform absolute concordance of dif-
ferential expression upon cytokine treatment. Inter-
platform concordance of differential expression detected by
human AGL array and TLDA across different normalization
methods and no normalization were exemplarily shown for the
effect of cytokine treatment. The overlapping number of miRNAs
between datasets was depicted for all possible inter-platform
combinations of distinctively normalized datasets.
(TIF)
Figure S6 Fold-change compression by microarray
profiling. Inter-platform fold-change concordance of human
and mouse TLDA and AGL platform of the miRNA subset
common on both platforms was illustrated by scatter plot of mean
values of fold-changes (log2 scale or Cq, respectively). A fold-
change compression of AGL platform values relative to the TLDA
platform was indicated by linear regression (black line) shown with
95% confidence band (blue line) and 95% prediction band (red
line).
(TIF)
Figure S7 Inter-platform concordance of t-values re-
veals compression of t-values by qPCR profiling. Inter-
platform concordance of t-values of human and mouse TLDA and
AGL platform for the common miRNA subsets was illustrated by
scatter plot. A compression of t-values of TLDA platform relative
to the AGL platform was indicated by linear regression (black line)
shown with 95% confidence band (blue line) and 95% prediction
band (red line).
(TIF)
Table S1 Normalization reduced mean inter-replicate
variances within the platform-overlapping miRNA sub-
sets of AGL arrays. The average of intra-replicate standard
deviations in human and mouse myoblasts, myotubes, and
cytokine treated myotubes were illustrated based on the plat-
form-overlapping miRNA datasets.
(XLSX)
Table S2 Normalization reduced mean inter-replicate
variances within the platform-overlapping miRNA sub-
sets of TLDA cards. Legend information as stated for Table S1.
(XLSX)
Table S3 The number of differentially expressed miR-
NAs within the platform-overlapping miRNA subsets of
AGL arrays. The mean number of differentially expressed
miRNAs which were identified in distinctively normalized human
and mouse myoblast differentiation and cytokine treated samples
within the platform-overlapping miRNA subsets were depicted.
(XLSX)
Table S4 The number of differentially expressed miR-
NAs within the platform-overlapping miRNA subsets of
TLDA cards. Legend information as specified for Table S3.
(XLSX)
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